Answers are grounded in this paper and cite their sources.
SQSTM1/p62 is a multifunctional selective autophagy receptor and stress-responsive scaffold protein that integrates autophagy, oxidative stress responses, inflammation, and metabolic signaling. Initially characterized as an autophagic adaptor for ubiquitinated cargo, SQSTM1/p62 is now recognized as a central signaling hub that shapes tumor initiation, progression, metastasis, and therapeutic resistance. Its diverse biological activities arise from a modular domain architecture, dynamic post-translational modifications, and context-dependent interactions with key regulators including LC3, KEAP1, TRAF6, and mTORC1-associated components. In cancer, SQSTM1/p62 can exert both tumor-suppressive and tumor-promoting effects, depending on the cellular lineage, stage of tumorigenesis, autophagic competence, subcellular localization, and microenvironmental context. In this review, we summarize the structural basis of SQSTM1/p62 function, the multilayered mechanisms regulating its expression and activity, and the major signaling pathways organized by SQSTM1/p62 in tumor cells and the tumor microenvironment. We further discuss recent progress in pharmacological targeting of SQSTM1/p62 and highlight the challenges of selectively inhibiting oncogenic SQSTM1/p62 signaling without disrupting its essential physiological functions. Collectively, this review positions SQSTM1/p62 as a context-dependent molecular integrator and a promising, yet complex, therapeutic target in cancer.
No takes yet. Share an insight, caveat, or question.
Liu et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: